ArticleFrontiers in pharmacology2020

Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients.

Jordi Cano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.